Current Neuropharmacology
Title:Psychobiology of Eating Disorders – a Gateway to Precision Medicine
Volume: 16 Issue: 8
Author(s): Stephan Zipfel and Ulrike Schmidt
Affiliation:
Export Options
About this article
Cite this article as:
Zipfel Stephan and Schmidt Ulrike , Psychobiology of Eating Disorders – a Gateway to Precision Medicine, Current Neuropharmacology 2018; 16 (8) . https://dx.doi.org/10.2174/1570159X1608180821144325
DOI https://dx.doi.org/10.2174/1570159X1608180821144325 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
33
3
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Diabetes Mellitus Type 2 and Functional Foods of Plant Origin
Recent Patents on Biotechnology Adenosine Monophosphate-activated Protein Kinase (AMPK) Activators For the Prevention, Treatment and Potential Reversal of Pathological Pain
Current Drug Targets Zinc and Copper Homeostasis in Head and Neck Cancer: Review and Meta-Analysis
Current Medicinal Chemistry From the Editors Perspective: Rational Approaches for Radical Entities
Current Neurovascular Research Somatic Drugs for Psychiatric Diseases: Aspirin or Simvastatin for Depression?
Current Neuropharmacology Targeting MCP-1 to Reduce Vascular Complications of Obesity
Recent Patents on Cardiovascular Drug Discovery Autophagy in Diabetic Retinopathy
Current Neuropharmacology Systemic Injections of Primidone Cause Wake-Inducing Effects in Rats
Current Psychopharmacology The Boundary between Hypochondriasis, Personality Dysfunction, and Trauma
Current Psychiatry Reviews Release of Adenosine and ATP During Ischemia and Epilepsy
Current Neuropharmacology Hyperhomocysteinemia, Pteridines and Oxidative Stress
Current Drug Metabolism Lack of Data on Depression-like States and Antidepressant Pharmacotherapy in Patients with Epilepsy: Randomised Controlled Trials are Badly Needed
Current Pharmaceutical Design ADAM8/MS2/CD156, an Emerging Drug Target in the Treatment of Inflammatory and Invasive Pathologies
Current Pharmaceutical Design Proteome Adjustments Post Gradual Hypoxic Stress in Barilius bendelisis: Insights into Adaptive Strategies of a Hill Stream Cyprinid
Current Proteomics Monoamine Oxidase Inhibitors: Perspective Design for the Treatment of Depression and Neurological Disorders
Current Enzyme Inhibition TNFα as Therapeutic Target: New Drugs, More Applications
Current Drug Targets - Inflammation & Allergy Mechanisms of Neutrophil-mediated Disease: Innovative Therapeutic Interventions
Current Pharmaceutical Design Quantitative Measurement of Some Physico-Chemical Parameters for the Medicinally Useful Natural Products
Letters in Drug Design & Discovery New Methods to Explore Marine Resources for Alzheimers Therapeutics
Current Alzheimer Research Glycolipid Stimulators for NKT Cells Bearing Invariant Vα19-Jα33 TCR α Chains
Mini-Reviews in Medicinal Chemistry